Stay updated on NIMBLe Study: Clinical Trial_hyperMutated Cancers

Sign up to get notified when there's something new on the NIMBLe Study: Clinical Trial_hyperMutated Cancers page.
Latest website image capture
Clouds background image

Latest updates to the NIMBLe Study: Clinical Trial_hyperMutated Cancers page

  1. Check
    3 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-11T14:41:10.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; the prior v3.4.1 notice was removed. These changes are limited to system-level updates and do not affect study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:27:19.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and NIH operations. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T04:05:29.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Added a glossary toggle and new metadata labels, including 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with a new revision tag 'v3.4.0'. The previous label variants 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' and the older revision 'v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-28T00:43:58.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.3 to v3.3.4. No substantive changes to study details, locations, or eligibility are visible in the screenshots.
    Difference
    0.1%
    Check dated 2026-01-14T01:00:14.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Locations section added listing New York, Alberta, British Columbia, and Ontario; HHS Vulnerability Disclosure removed; location headings consolidated under a single Locations section (Revision: v3.3.3).
    Difference
    0.5%
    Check dated 2025-12-23T09:47:20.000Z thumbnail image

Stay in the know with updates to NIMBLe Study: Clinical Trial_hyperMutated Cancers

Enter your email address, and we'll notify you when there's something new on the NIMBLe Study: Clinical Trial_hyperMutated Cancers page.